RxERP and p-Chip Corporation to Present Hardware-Backed Item Identity Solution at GS1 Connect 2026
RxERP and p-Chip Corporation today announced that the companies will jointly present their combined Hardware-Backed Item Identity Solution at GS1 Connect 2026 in Las Vegas on June 10, 2026. The session, "Beyond the Barcode: The Physical-Digital Connection - Linking GS1 Identification to Products," will demonstrate how unit-level digital anchors can be bound to GS1 identifiers and EPCIS events to strengthen pharmaceutical traceability.
p-Chip Corporation, Choice One Rx, and RxERP Launch Precedent-Setting Trial Demonstrating Digital Traceability of Drug Supply Chains and Chain-of-Identity for DSCSA Compliance, Co-Sponsored by Avantor
p-Chip Corporation, Choice One Rx, and RxERP, today announced a partnership to conduct a precedent-setting trial demonstrating end-to-end digital traceability. The trial will demonstrate advanced traceability of drugs for Oncology, Urology, Rheumatology and Gastroenterology across pharmaceutical supply chains for over 1,000 patients through to 2028. The trial is designed to validate compliance with the U.S. Drug Supply Chain Security Act (DSCSA) to establish verifiable Chain-of-Identity and Chain-of-Custody for individual prescriptions. The trial is co-sponsored by Avantor, a leading global provider of mission-critical laboratory and clinical consumables for the life sciences and healthcare sectors.
